Nureca Limited Cash Flow Conversion Efficiency
Nureca Limited cash flow conversion efficiency. Based on the latest financial reports, Nureca Limited (NURECA) has a cash flow conversion efficiency ratio of 0.022x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs44.46 Million ≈ $480.82K USD) by net assets (Rs1.99 Billion ≈ $21.49 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Cash Flow Conversion Efficiency of Nureca Limited (2017–2025)
Cash flow conversion efficiency of Nureca Limited from 2017 to 2025. This chart illustrates how Nureca Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Nureca Limited share price for real-time trading data and today's change.
Nureca Limited Cash Flow Conversion Ratio Explained
Nureca Limited cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.
Nureca Limited Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Nureca Limited ranked by their cash flow conversion efficiency. Also see how much is Nureca Limited worth for the company's overall valuation and market capitalisation.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Sun Race Sturmey-Archer Inc
TW:1526
|
0.044x |
|
Adveritas Ltd
AU:AV1
|
5.266x |
|
Oncoinvent ASA
OL:ONCIN
|
-0.505x |
|
SCI Information Service Inc
KQ:036120
|
0.049x |
|
Ege Seramik Sanayi ve Ticaret AS
IS:EGSER
|
-0.103x |
|
Commerce Resources Corp.
V:CCE
|
-0.001x |
|
NUREXONE BIOLOGIC INC.
F:J90
|
-0.426x |
|
Italy Innovazioni SpA
PA:MLITN
|
N/A |
Annual Cash Flow Conversion Efficiency for Nureca Limited (2017–2025)
The table below shows the annual cash flow conversion efficiency of Nureca Limited from 2017 to 2025. Review free cash flow generation of Nureca Limited to assess how much free cash flow the company generates relative to operating cash flow.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-03-31 | Rs1.94 Billion ≈ $21.01 Million |
Rs-190.83 Million ≈ $-2.06 Million |
-0.098x | -599.40% |
| 2024-03-31 | Rs1.93 Billion ≈ $20.88 Million |
Rs-27.12 Million ≈ $-293.29K |
-0.014x | -126.76% |
| 2023-03-31 | Rs1.95 Billion ≈ $21.08 Million |
Rs102.27 Million ≈ $1.11 Million |
0.052x | +662.22% |
| 2022-03-31 | Rs2.03 Billion ≈ $21.98 Million |
Rs13.99 Million ≈ $151.30K |
0.007x | -96.78% |
| 2021-03-31 | Rs1.63 Billion ≈ $17.64 Million |
Rs348.67 Million ≈ $3.77 Million |
0.214x | +140.30% |
| 2020-03-31 | Rs149.34 Million ≈ $1.62 Million |
Rs-79.23 Million ≈ $-856.84K |
-0.531x | -1581.51% |
| 2019-03-31 | Rs85.45 Million ≈ $924.11K |
Rs3.06 Million ≈ $33.09K |
0.036x | -37.78% |
| 2018-03-31 | Rs17.20 Million ≈ $186.01K |
Rs990.00K ≈ $10.71K |
0.058x | +106.30% |
| 2017-03-31 | Rs102.45K ≈ $1.11K |
Rs-93.62K ≈ $-1.01K |
-0.914x | -- |
About Nureca Limited
Nureca Limited provides home healthcare and wellness products in India. The company offers chronic disease products, such as nebulizers, blood pressure monitors, finger pulse oximeters, glucose meters, and thermometers, as well as connected products; orthopedic products, including massagers, pain management products, posture correctors, and rehabilitation products; and humidifiers and steamers, p… Read more